Forecast: Trachea, Bronchus or Lung Malignant Neoplasms Mortality in Japan

The mortality rate from trachea, bronchus, or lung malignant neoplasms in Japan is projected to increase modestly from 61.6 deaths per hundred thousand in 2024 to 63.2 by 2028. This represents a consistent year-on-year growth of approximately 0.65%. The compound annual growth rate (CAGR) over the five years from 2024 to 2028 is roughly 0.65% as well. In 2023, the mortality rate was slightly below the forecasted 2024 level.

Future trends to watch include:

• Impacts of public health interventions, such as smoking cessation programs.
• Innovations in medical treatments and early diagnosis.
• Demographic shifts, particularly aging population dynamics.